A retrospective case-control study involving 192 women with PE and 219 normotensive controls. Compared to the other hematological indices, LMR is a robust, cost-effective biomarker with superior perfo
Technological advancements in the Preeclampsia Laboratory Testing industry are shaping the future market landscape. The report evaluates innovation-driven growth and how emerging technologies are tran
Congo red detection and false-positive rates according to scoring subset, type of preeclampsia, characteristics, preeclampsia risk factors and initial assessments.
